Z-Val-Lys-Met-AMC acetate salt
CAS: 141223-71-4
Ref. 3D-FV110562
10mg | 343,00 € | ||
25mg | 572,00 € | ||
50mg | 948,00 € | ||
100mg | 1.552,00 € | ||
250mg | 3.374,00 € |
Información del producto
- Z-Val-Lys-Met-AMC
Bortezomib is a proteasome inhibitor that binds to the catalytic site of the proteasome and inhibits its activity. Bortezomib is used as an anticancer agent to treat multiple myeloma, T-cell lymphomas, and other cancers. It has been shown to inhibit the growth of cancer cells and slow tumor progression in animal models. The drug has also been shown to decrease insulin resistance in mice with high blood sugar levels by inhibiting histone deacetylase (HDAC). This inhibition leads to increased expression of genes that are involved in glucose metabolism and decreased expression of genes that regulate fat production.
The drug also binds tightly to the insulin receptor, which may lead to improved glucose uptake into cells.
Propiedades químicas
Consulta técnica sobre: 3D-FV110562 Z-Val-Lys-Met-AMC acetate salt
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.